<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01601574</url>
  </required_header>
  <id_info>
    <org_study_id>WW-MUSC-1201</org_study_id>
    <nct_id>NCT01601574</nct_id>
  </id_info>
  <brief_title>Weight Loss Study for People With Type 2 Diabetes</brief_title>
  <acronym>T2D</acronym>
  <official_title>Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Weight Watchers International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the Weight Watchers program modified for
      use by people with Type 2 diabetes results in more improvements in blood glucose control
      relative to a control group receiving standard diabetes counseling.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in BMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in waist circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in fasting blood glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in HOMA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in cardiovascular risk markers (lipid measures, blood pressure, C-Reactive Protein)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in diabetes medications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Change in various mental health assessments</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">563</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Modified Weight Watchers program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Diabetes Counseling group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Weight Watchers modified program</intervention_name>
    <description>Weight Watchers: For people with Type 2 diabetes including (1) weekly standard in-person Weight Watchers meetings, (2) use of the standard Weight Watchers online program and tools, and (3) two scheduled telephone consultations with a Certified Diabetes Educator (CDE) who will assist the participant in tailoring the standard Weight Watchers program to accommodate the participant's diabetes-related status, with additional unlimited phone and email access to CDEs at the participant's request</description>
    <arm_group_label>Modified Weight Watchers program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Care group</intervention_name>
    <description>One session of in-person diabetic nutritional counseling with a registered dietitian, with follow-up written educational materials.</description>
    <arm_group_label>Standard Diabetes Counseling group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Participant reported diagnosis of Type II diabetes

          2. HbA1c between 7%‐11% (inclusive)

          3. Fasting blood glucose &lt; 240. If a potential participant has a FBG above the inclusion
             criteria it is acceptable to re‐test this potential participant within one week of the
             original test.

          4. BMI 27‐50 kg/m2 (inclusive)

          5. Age range - 18 - 70 (inclusive)

          6. Clearance on medical exam by study physician including EKG

          7. No weight loss over the previous 3 months (5kg loss is acceptable with physician
             discretion)

          8. On stable regimen of all medications (including diabetes) for at least 3 months (brief
             regimens of medications such as antibiotics, steroids, etc. are permitted)

          9. All diabetes medications are permitted including insulin.

         10. Willing and able to commit to regular physical activity (e.g. walking) five days per
             week

         11. Willingness and ability to make all scheduled appointments required by study protocol

         12. Willingness to attend weekly Weight Watchers meetings in the community and to
             participate in Weight Watchers online program, if so randomized

         13. Willing to follow requirements of study protocol

         14. Willing and able to provide a valid email address for use in the study

         15. Must be able to communicate (oral and written) in English

         16. Under the care of a physician for diabetes and willing to give release to contact the
             MD and request MD's agreement for participant to participate -

        Exclusion Criteria:

          1. Type 1 Diabetes

          2. Cardiovascular/Coronary Heart Disease [e.g., MI or CVA within last 6 months, TIA,
             clinically significant arrhythmias, uncontrolled hypertension (defined as blood
             pressure over 160/110); physician's discretion may be more conservative]

          3. Current severe depression or history of severe depression within the previous year,
             based on DSM‐IV‐TR criteria for Major Depressive Episode

          4. Taking prescription or OTC weight loss medications within last 4 weeks

          5. Currently taking other medications that affect weight (e.g., paroxetine, tricyclics,
             anti‐psychotics)

          6. Within the last 4 weeks, use of chromium supplements or any nutrition supplements or
             herbal products claimed to have a weight loss effect. Participants using other
             non‐excluded nutrition supplements or herbal products must agree to continue at their
             current level of use throughout the study.

          7. Participation in a weight control program within the past 3 months

          8. QTc interval &gt;450 msec for males and QTc interval &gt;470 msec for females

          9. PHQ‐9 total score &gt; 15

         10. Thyroid disease for which the participant is untreated or has had treatment changed
             within the last 6 months. History of thyroid disease or current thyroid disease
             treated with a stable medication regimen for at least 6 months is acceptable

         11. History of a surgical procedure for weight loss at any time (e.g. gastroplasty,
             gastric by‐pass, gastrectomy or partial gastrectomy, adjustable banding, gastric
             sleeve)

         12. History of major surgery within three months of enrollment

         13. Presence of implanted cardiac defibrillator

         14. Orthopedic limitations that would interfere with ability to engage in regular physical
             activity

         15. Gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer
             disease, Crohn's disease, chronic diarrhea or active gallbladder disease

         16. Current cancer or cancer treatment, or a history of cancer or cancer treatment within
             the last 3 years. Persons with successfully resected basal cell carcinoma of the skin
             may be enrolled if treatment was completed more than 6 months prior to enrollment.

         17. History, within the past five years, of clinically diagnosed eating disorders
             Confidential March 30, 2012 9 including anorexia nervosa or bulimia nervosa.

         18. Women who are pregnant, lactating , trying to become pregnant or unwilling to use an
             effective means of birth control

         19. Participation in another clinical trial within 30 days prior to enrollment.

         20. Currently consuming &gt;14 alcoholic drinks (1 drink = 12 fl oz beer, 4 fl oz wine or 1.5
             fl oz liquor) per week and unwilling to limit intake to less than 3 drinks per
             drinking day during study participation

         21. Current or past drug abuse

         22. Participation in trial by another member of household

         23. Hypoglycemic Events:

             a. Evidence of more than 1 severe hypoglycemic event in the past 12 months, unless the
             participant's treating physician provides written clearance for participation.

         24. Any other condition or factor which in the opinion of the study physician or
             investigator makes it inadvisable for the candidate to participate in the trial -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick M. O'Neil, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabetes Research and Training Center, University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Clinical Research</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CSRA Partners in Health</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909-6599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University Feinberg School</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Obesity Research Center St. Luke's Roosevelt Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Medical College of Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Nutrition and Preventive Medicine</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28277</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Obesity Clinical Trials Program Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Your Diabetes Endocrine Nutrition Group Inc.</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Weight Loss Surgery, LLC</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Pennsylvania Center for Weight and Eating Disorders</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Endocrine Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246-1906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oakwell Clinical Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Center for Weight Management &amp; Research, Inc The Navy League Building</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.med.upenn.edu/weight</url>
    <description>The University of Pennsylvania Center for Weight and Eating Disorders</description>
  </link>
  <link>
    <url>http://www.yourdiabetes.net</url>
    <description>Your Diabetes Endocrine Nutrition Group, Inc</description>
  </link>
  <link>
    <url>http://MUSChealth.com/weight</url>
    <description>Medical University of South Carolina</description>
  </link>
  <link>
    <url>http://www.dukehealth.org/clinicaltrials</url>
    <description>Obesity Clinical Trials Program Duke University Medical Center</description>
  </link>
  <link>
    <url>http://www.weightresearch.net</url>
    <description>Comprehensive Weight Control Program Weill Medical College of Cornell University</description>
  </link>
  <link>
    <url>http://www.oregonweightlosssurgery.com</url>
    <description>Oregon Weight Loss Surgery, LLC</description>
  </link>
  <link>
    <url>http://www.scripps.org/services__clinical-research__active-studies</url>
    <description>Scripps Nutrition and Metabolic &amp; Research</description>
  </link>
  <link>
    <url>http://www.uab.edu/nutrition/</url>
    <description>University of Alabama at Birmingham Department of Nutrition</description>
  </link>
  <link>
    <url>http://www.wtmgmt.com</url>
    <description>The Washington Center for Weight Management &amp; Research</description>
  </link>
  <link>
    <url>http://www.baylorhealth.edu/research/Pages/default.aspx</url>
    <description>Baylor Health</description>
  </link>
  <link>
    <url>http://www.baylorhealth.com/AdvancingMedicine/pages/default.aspx</url>
    <description>Baylor Research</description>
  </link>
  <link>
    <url>http://www.oakwellclinical.com</url>
    <description>Oakwell Clinical Research</description>
  </link>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2012</study_first_submitted>
  <study_first_submitted_qc>May 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2012</study_first_posted>
  <last_update_submitted>October 14, 2014</last_update_submitted>
  <last_update_submitted_qc>October 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>HbA1c</keyword>
  <keyword>Overweight</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

